[Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].


The antihypertensive effect of debrisoquine (20 mg/day), methyldopa (100 mg/day) and propranolol (160 mg/day) was compared to that obtained with a placebo in a controlled trial carried out by a group of 14 internists. Forty-eight patients with uncomplicated essential hypertension were included. Mefruside (25 mg/day) was first given alone for 6 weeks ("open… (More)


  • Presentations referencing similar topics